Evidence map›Paper›PMID 40869289›Full record

ArticleInternational journal of molecular sciences2025

Galactooligosaccharides Promote Gut Barrier Integrity and Exert Anti-Inflammatory Effects in DSS-Induced Colitis Through Microbiota Modulation.

Lucila A Godínez-Méndez, Alejandra Natali Vega-Magaña, Marcela Peña-Rodríguez, Gisela Anay Valencia-Hernández, Germán Muñoz-Sánchez, Liliana Iñiguez-Gutiérrez, Rocío López-Roa, Martha Eloisa Ramos-Márquez, Mary Fafutis-Morris, Vidal Delgado-Rizo

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lucila A Godínez-MéndezCentro de Investigación en Inmunología y Dermatología (CIINDE), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0002-1631-2370
Alejandra Natali Vega-MagañaLaboratorio de Diagnóstico en Enfermedades Emergentes y Reemergentes (LADEER), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0003-4749-2498
Marcela Peña-RodríguezLaboratorio de Diagnóstico en Enfermedades Emergentes y Reemergentes (LADEER), Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0003-3016-4295
Gisela Anay Valencia-HernándezCentro de Investigación en Inmunología y Dermatología (CIINDE), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.
Germán Muñoz-SánchezCentro de Investigación en Inmunología y Dermatología (CIINDE), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0001-5573-3648
Liliana Iñiguez-GutiérrezDepartamento Académico de Ciencias Básicas, Universidad Autónoma de Guadalajara, Av. Patria 120, Zapopan 45129, Mexico.
Rocío López-RoaLaboratorio de Investigación y Desarrollo Farmacéutico (LIDF), Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Mexico.ORCID 0000-0002-2339-4108
Martha Eloisa Ramos-MárquezDepartamento de Biología Molecular y Genómica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0003-4064-5578
Mary Fafutis-MorrisCentro de Investigación en Inmunología y Dermatología (CIINDE), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.ORCID 0000-0002-5384-1175
Vidal Delgado-RizoCentro de Investigación en Inmunología y Dermatología (CIINDE), Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis is a chronic inflammatory bowel disease characterized by persistent inflammation, immune dysregulation, gut microbiota alterations, and impaired epithelial barrier function.

Indexed as

Anti-Inflammatory AgentsColitisColitis, UlcerativeGastrointestinal MicrobiomeOligosaccharidesAnimalsColonCytokinesDextran SulfateDisease Models, AnimalIntestinal MucosaMaleMiceMice, Inbred C57BLPrebioticsAnti-Inflammatory AgentsCytokinesDextran SulfateOligosaccharidesPrebioticsgalactooligosaccharidesLupinusMCT1MCT4microbiotaulcerative colitis

Identifiers

PMID40869289
PMCPMC12386736

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.